# Intranasal Dexmedetomidine for Acute Anxiety State in Adults

> **NCT07550881** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Tongji University** · enrollment: 150 (estimated)

## Conditions studied

- Acute Anxiety States

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT07550881
- **Lead sponsor:** Tongji University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07550881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07550881, "Intranasal Dexmedetomidine for Acute Anxiety State in Adults". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07550881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*